1.上海市第十人民医院崇明分院中医内科,上海 202157
2.上海中医药大学附属市中医医院血液病科,上海 200071
3.上海中医药大学附属岳阳中西医结合医院血液内科,上海 200437
任梓瑞,女,28岁,硕士,住院医师。研究方向:中医药治疗血液病等内科疾病。
鲍计章,E-mail:baojizhang@shutcm.edu.cn
收稿:2025-04-30,
纸质出版:2026-03-25
移动端阅览
任梓瑞,王圣勇,陆皓,等.扶正祛邪法联合减量去甲基化方案治疗老年急性髓系白血病的疗效与机制研究[J].北京中医药,2026,45(3):310-316.
REN Zirui,WANG Shengyong,LU Hao,et al.Clinical efficacy and mechanisms of Fuzheng Quxie Method combined with reduced-dose demethylation regimen in the treatment of acute myeloid leukemia in the elderly[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(03):310-316.
任梓瑞,王圣勇,陆皓,等.扶正祛邪法联合减量去甲基化方案治疗老年急性髓系白血病的疗效与机制研究[J].北京中医药,2026,45(3):310-316. DOI: 10.16025/j.1674-1307.2026.03.005.
REN Zirui,WANG Shengyong,LU Hao,et al.Clinical efficacy and mechanisms of Fuzheng Quxie Method combined with reduced-dose demethylation regimen in the treatment of acute myeloid leukemia in the elderly[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(03):310-316. DOI: 10.16025/j.1674-1307.2026.03.005.
目的
2
观察扶正祛邪法(扶正祛邪复方加定清片)联合减量去甲基化方案治疗老年急性髓系白血病(acute myeloid leukemia,AML)的疗效及对转录激活因子4(activating transcription factor 4,ATF4)和白介素-6(interleukin-6,IL-6)的影响。初步探讨扶正祛邪法对老年急性髓系白血病的作用机制。
方法
2
选择2021年8月至2022年12月在上海中医药大学附属岳阳中西医结合医院血液内科诊治的符合标准的60例老年AML(非M3型)患者,随机分为观察组、对照组2组,各30例。观察组采用扶正祛邪法联合减量去甲基化方案治疗,对照组采用标准去甲基化方案治疗,1个疗程为4周,3个疗程后进行统计分析和疗效评价,比较2组患者中医证候疗效、西医疗效、血常规、原始细胞比例、ATF4表达、IL-6水平。
结果
2
观察组总有效率、中医证候疗效均优于对照组,在抑制白细胞异常增殖、提升血小板及血红蛋白方面也优于对照组;观察组ATF4表达治疗后高于治疗前,对照组无明显变化;治疗后2组IL-6水平均有所下降,观察组IL-6水平下降更为显著。
结论
2
扶正祛邪法联合减量去甲基化方案治疗老年AML临床疗效以及中医证候疗效具有显著优势,能够有效抑制白细胞异常增殖,升高血小板及血红蛋白,且在基因表达和抑制炎症方面也具有优势。
Objective
2
To observe the efficacy of the
Fuzheng Quxie Method
(
Fuzheng Quxie
compound formula combined with
Dingqing Tablets
) in combination with a reduced-dose demethylation regimen for the treatment of elderly patients with acute myeloid leukemia (AML), and to investigate its effects on activating transcription factor 4 (ATF4) and interleukin-6 (IL-6), thereby preliminarily exploring its mechanisms of action in elderly AML.
Methods
2
Sixty elderly patients with non-M3 AML who met the inclusion criteria and were treated in the Department of Hematology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, from August 2021 to December 2022 were enrolled. Patients were randomly divided into two groups, with 30 cases in the observation group and 30 cases in the control group. The observation group was treated with the
Fuzheng Quxie Method
(
Dingqing Tablets
combined with
Fuzheng Quxie
compound formula) plus a reduced-dose demethylation regimen, while the control group received standard demethylation therapy. One treatment course was 4 weeks, and after 3 courses, clinical data were collected for efficacy evaluation and statistical analysis. Outcomes included traditional Chinese medicine (TCM) syndrome efficacy, Western medical efficacy, routine blood parameters, p
roportion of blast cells, ATF4 expression, and IL-6 levels.
Results
2
The observation group showed superior total effective rate and TCM syndrome efficacy compared with the control group. It also demonstrated better effects in inhibiting abnormal leukocyte proliferation and improving platelet and hemoglobin levels. ATF4 expression in the observation group increased after treatment compared with that before treatment, while no significant change was observed in the control group. After treatment, IL-6 levels decreased in both groups, with a more significant reduction observed in the observation group.
Conclusion
2
The
Fuzheng Quxie Method
combined with a reduced-dose demethylation regimen shows significant advantages in both clinical efficacy and TCM syndrome improvement in elderly AML patients. It can effectively inhibit abnormal leukocyte proliferation, increase platelet and hemoglobin levels, and also demonstrates advantages in regulating gene expression and suppressing inflammatory responses.
SHIMONY S , STAHL M , STONE RM . Acute myeloid leukemia:2023 update on diagnosis,risk‐stratification,and management [J ] . Am J Hematol , 2023 , 98 ( 3 ): 502 - 526 .
DöHNER H , WEI AH , LöWENBERG B . Towards precision medicine for AML [J ] . Nat Rev Clin Oncol , 2021 , 18 ( 9 ): 577 - 590 .
PALMIERI R , PATERNO G , DE BELLIS E , et al . Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of Fitness [J ] . Cancers (Basel) , 2020 , 12 ( 1 ): 120 .
ALFAYEZ M , KANTARJIAN H , KADIA T , et al . Emerging drug profile:CPX-351(vyxeos) in AML [J ] . Leuk Lymphoma , 2020 , 61 ( 2 ): 288 - 297 .
李昌桂 , 李晓靖 , 朱文伟 , 等 . 定清片治疗正虚毒蕴证急性髓系白血病患者的临床疗效 [J ] . 时珍国医国药 , 2022 , 33 ( 8 ): 1922 - 1924 .
张晓丹 , 周永明 , 王巍 . 中药对人急性髓系白血病细胞株HL-60的作用机制 [J ] . 长春中医药大学学报 , 2021 , 37 ( 4 ): 909 - 913 .
中华医学会血液学分会白血病淋巴瘤学组 . 中国成人急性髓系白血病(非急性早幼粒细胞白血病)诊疗指南(2021年版) [J ] . 中华血液学杂志 , 2021 , 42 ( 8 ): 617 - 623 .
郑筱萸 . 中医新药临床研究指导原则(试行) [M ] . 北京 : 中国医药科技出版社 , 2002 : 27 - 28 .
张之南 , 沈悌 . 血液病诊断及疗效标准 [M ] . 4版 . 北京 : 科学出版社 , 2018 : 131 - 133,271 .
MALIK P , CASHEN AF . Decitabine in the treatment of acute myeloid leukemia in elderly patients [J ] . Cancer Manag Res , 2014 , 6 : 53 - 61 .
张禹成 , 闫理想 , 陈猛 , 等 . 从“浊邪害清”论骨髓微环境与白血病的关系及中医辨治 [J ] . 北京中医药大学学报 , 2023 , 46 ( 10 ): 1467 - 1472 .
张晓丹 , 周永明 , 严静贤 . 中医药治疗急性髓系白血病的研究进展 [J ] . 中国中医急症 , 2020 , 29 ( 5 ): 925 - 929 .
徐熠 , 杨月红 , 黄瑾 , 等 . 某三甲中西医结合医院自制制剂定清片临床应用分析 [J ] . 药学实践与服务 , 2023 , 41 ( 11 ): 680 - 685 .
孙伟玲 , 郑丹丹 , 周永明 . 定清片对人急性髓系白血病HL-60细胞侵袭力的影响 [J ] . 西部中医药 , 2018 , 31 ( 6 ): 10 - 12 .
ZHENG D , ZHOU Y , LIU Y , et al . Molecular Mechanism Investigation on Monomer Kaempferol of the Traditional Medicine Dingqing Tablet in Promoting Apoptosis of Acute Myeloid Leukemia HL-60 Cells [J ] . Evid Based Complement Alternat Med , 2022 , 2022 : 8383315 .
王崇敏 , 李军 , 晋海军 , 等 . 太子参多糖的研究进展 [J ] . 食品安全质量检测学报 , 2021 , 12 ( 24 ): 9481 - 9489 .
王小兰 , 段鹏飞 , 杨梦 , 等 . 生地黄多糖对环磷酰胺诱导的免疫抑制小鼠的免疫调节作用研究 [J ] . 上海中医药大学学报 , 2021 , 35 ( 1 ): 55 - 60,92 .
饶丽华 , 章国良 , 席启辉 , 等 . 白花蛇舌草总黄酮对多药耐药白血病CEM/VCR细胞增殖凋亡的影响 [J ] . 实验与检验医学 , 2022 , 40 ( 3 ): 271 - 274 .
冯嘉昆 , 刘伟 , 李正发 , 等 . 半夏提取物调节Bax、Bcl-2、Caspase-3蛋白表达诱导白血病细胞凋亡 [J ] . 中国组织工程研究 , 2020 , 26 ( 31 ): 5023 - 5029 .
江宝瑞 , 丁宏 , 王跃 , 等 . 枳壳的药理研究进展 [J ] . 云南中医中药杂志 , 2022 , 43 ( 6 ): 70 - 75 .
余世荣 , 周本宏 , 刘芳 . 薜荔果本草考证及现代研究概况 [J ] . 中国药师 , 2010 , 13 ( 9 ): 1343 - 1345 .
李洁 , 刘盼盼 . 半枝莲逆转白血病细胞株K562/A02耐药性的实验研究 [J ] . 中医药导报 , 2012 , 18 ( 5 ): 88 - 89 .
刘海英 , 司文涛 , 李育林 , 等 . 中医药治疗骨髓增生异常综合征的现状及机制研究进展 [J ] . 北京中医药 , 2025 , 44 ( 2 ): 246 - 252 .
AMERI K , HARRIS AL . Activating transcription factor 4 [J ] . Int J Biochem Cell Biol , 2008 , 40 ( 1 ): 14 - 21 .
毛启远 , 张英 , 李道睿 , 等 . 基于肿瘤干细胞诱导多核型髓源抑制性细胞形成介导免疫逃逸探讨中医扶正解毒法防治肿瘤转移的可能机制 [J ] . 北京中医药 , 2023 , 42 ( 7 ): 782 - 785 .
BAO J , ZHAO X , LU J , et al . Platelet transcriptome profiles provide potential therapeutic targets for elderly acute myelocytic leukemia patients [J ] . J Transl Med , 2021 , 19 ( 1 ): 388 .
ZHAO Z , DONG Q , LIU X , et al . Dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest [J ] . Genomics , 2020 , 112 ( 2 ): 1309 - 1317 .
SRIVASTAVA RK , LI C , AHMAD A , et al . ATF4 regulates arsenic trioxide-mediated NADPH oxidase, ER-mitochondrial crosstalk and apoptosis [J ] . Arch Biochem Biophys , 2016 , 609 : 39 - 50 .
ZHANG Y , GUO H , ZHANG Z , et al . IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia [J ] . Exp Cell Res , 2022 , 415 ( 1 ): 113112 .
BRENJIAN S , MOINI A , YAMINI N , et al . Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers [J ] . Am J Reprod Immunol , 2020 , 83 ( 1 ): e13186 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备 11010102006710号